Temporal changes in the incidence of ductal carcinoma in situ in Goiânia, Brazil: a population-based study
DOI:
https://doi.org/10.29289/2594539420240002Palavras-chave:
breast carcinoma in situ, breast neoplasms, incidence, epidemiology, cesiumResumo
Mammography screening has resulted in a considerable increase in the diagnosis of early-stage tumors in various countries. However, most available data refer to high-income countries, hospital-based studies, or studies with limited follow-up. Therefore the aim of this study was to determine the incidence of ductal carcinoma in situ (DCIS) in Goiânia, Brazil. Methods: Ecological study among residents of the city of Goiânia, Brazil. We included all the DCIS cases registered at the Goiânia population-based cancer registry between 1994 and 2010. Crude incidence and age-standardized incidence rates (using the world standard population) were calculated. Poisson regression was used to analyze temporal changes, with the average annual percent change (AAPC) in the crude and age-standardized incidence rates being calculated. Results: There were 261 cases of DCIS, with an annual incidence rate that ranged from 0.58 to 4.21 per 1,000 women (crude and standardized) over the period. The number of cases of DCIS in the 40–49 and 60–69-years age groups increased significantly (p<0.01). The AAPC of the crude incidence rate for the period was 11.88% per year (95%CI 9–15; p<0.01) and the standardized rate was 11.89% per year (95%CI 9–15; p<0.01).
Downloads
Referências
1. Liu Y, Shou K, Li J, Wu Q, Hu Y, Wang J, et al. Ductal carcinoma in situ of the breast: perspectives on tumor subtype and treatment. Biomed Res Int. 2020;2020:7251431. https://doi.org/10.1155/2020/7251431
2. Shehata M, Grimm L, Ballantyne N, Lourenco A, Demello LR, Kilgore MR, et al. Ductal carcinoma in situ: current concepts in biology, imaging, and treatment. J Breast Imaging. 2019;1(3):166-76. https://doi.org/10.1093/jbi/wbz039
3. Ward EM, DeSantis CE, Lin CC, Kramer JL, Jemal A, Kohler B, et al. Cancer statistics: breast cancer in situ. CA Cancer J Clin. 2015;65(6):481-95. https://doi.org/10.3322/caac.21321
4. Esserman L, Yau C. Rethinking the standard for ductal carcinoma in situ treatment. JAMA Oncol. 2015;1(7):881-3. https://doi.org/10.1001/jamaoncol.2015.2607
5. Oseni TO, Zhang B, Coopey SB, Gadd MA, Hughes KS, Chang DC. Twenty-five year trends in the incidence of ductal carcinoma in situ in US women. J Am Coll Surg. 2019;228(6):932-9. https://doi.org/10.1016/j.jamcollsurg.2019.01.018
6. Rodrigues DCN, Freitas-Junior R, Rahal RMS, Corrêa RS, Gouveia PA, Peixoto JE, et al. Temporal changes in breast cancer screening coverage provided under the Brazilian National Health Service between 2008 and 2017. BMC Public Health. 2019;19(1):959. https://doi.org/10.1186/s12889-019-7278-z
7. Medeiros JM, Linhares JC, Hatschbach SBB, Hubie DP, Rahman SA, Orlandi D, et al. Perfil epidemiológico e estudo de sobrevida dos pacientes com câncer de mama atendidos no Hospital Erasto Gaertner em Curitiba, PR. Rev Bras Mastologia. 2016;26(3):107-12. https://doi.org/10.5327/Z201600030005RBM
8. Costa AM, Hashim D, Fregnani JHTG, Weiderpass E. Overall survival and time trends in breast and cervical cancer incidence and mortality in the Regional Health District (RHD) of Barretos, São Paulo, Brazil. BMC Cancer. 2018;18(1):1079. https://doi.org/10.1186/s12885-018-4956-7
9. Makdissi FB, Leite FPM, Peres SV, Silva DRM, Oliveira MM, Lopez RVM, et al. Breast cancer survival in a Brazilian cancer center: a cohort study of 5,095 patients. Mastology. 2019;29(1):37-46. https://doi.org/10.29289/2594539420190000437
10. Moura L, Curado MP, Simões EJ, Cezário AC, Urdaneta M. Avaliação do registro de câncer de base populacional do município de Goiânia, estado de Goiás, Brasil. Epidemiol Serv Saúde. 2006;15(4):7-17. https://doi.org/10.5123/S1679-49742006000400002.
11. Lemos NAF, Freitas-Junior R, Moreira MAR, Silva TC, Oliveira JC, Silva CMB. Difficulties in collecting data on ductal carcinoma in situ at a Population-based Cancer Registry. Mastology. 2019;29(2):86-9. https://doi.org/10.29289/2594539420190000421
12. Boniol M, Heanue M. Age-standardisation and denominators. In: Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al., eds. Cancer incidence in five continents. Vol. IX. Lyon: IARC; 2009. p. 99-101.
13. Instituto Brasileiro de Geografia e Estatística. População. Diretoria e pesquisa. Departamento de população e indicadores sociais [Internet]. [cited on 2022 Mar 9]. Available from: https://www.ibge.gov.br/estatisticas-novoportal/sociais/populacao.html.
14. Doll R, Cook P. Summarizing indices for comparison of cancer incidence data. Int J Cancer. 1967;2(3):269-79. https://doi.org/10.1002/ijc.2910020310
15. National Cancer Institute. Division of Cancer Control & Population Sciences. Surveillance Research Program. Joinpoint trend analysis software [Internet]. 2019 [cited 2022 Mar 4]. https://surveillance.cancer.gov/joinpoint/
16. Passos CM, Sales JB, Maia EG, Caldeira TCM, Rodrigues RD, Figueiredo N, et al. Trends in access to female cancer screening in Brazil, 2007-16. J Public Health (Oxf). 2021;43(3):632-8. https://doi.org/10.1093/pubmed/fdaa028
17. Corrêa RS, Freitas-Junior R, Peixoto JE, Rodrigues DCN, Lemos MEF, Dias CM, et al. Effectiveness of a quality control program in mammography for the Brazilian National Health System. Rev Saude Publica. 2012;46(5):769-76. https://doi.org/10.1590/s0034-89102012000500002
18. Farhat GN, Walker R, Buist DSM, Onega T, Kerlikowske K. Changes in invasive breast cancer and ductal carcinoma in situ rates in relation to the decline in hormone therapy use. J Clin Oncol. 2010;28(35):5140-6. https://doi.org/10.1200/jco.2010.29.5121
19. Dos-Santos-Silva I, De Stavola BL, Renna Junior NL, Nogueira MC, Aquino EML, Bustamante-Teixeira MT, et al. Ethnoracial and social trends in breast cancer staging at diagnosis in Brazil, 2001-14: a case only analysis. Lancet Glob Health. 2019;7(6):e784-97. https://doi.org/10.1016/s2214-109x(19)30151-2
20. Migowski A, Silva GA, Dias MBK, Diz MDPE, Sant'Ana DR, Nadanovsky P. Guidelines for early detection of breast cancer in Brazil. II – new national recommendations, main evidence, and controversies. Cad Saude Publica. 2018;34(6):e00074817. https://doi.org/10.1590/0102-311x00074817
21. Siu AL; U.S. Preventive Services Task Force. Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2016;164(4):279-96. https://doi.org/10.7326/m15-2886
22. Glas NA, Craen AJM, Bastiaannet E, Op ’t Land EG, Kiderlen M, van de Water W, et al. Effect of implementation of the mass breast cancer screening programme in older women in the Netherlands: population based study. BMJ. 2014;349:g5410. https://doi.org/10.1136/bmj.g5410
23. Mannu GS, Wang Z, Broggio J, Charman J, Cheung S, Kearins O, et al. Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study. BMJ. 2020;369:m1570. https://doi.org/10.1136/bmj.m1570
24. Freitas Júnior R, Nunes RD, Martins E, Curado MP, Freitas NMA, Soares LR, et al. Prognostic factors and overall survival of breast cancer in the city of Goiania, Brazil: a population-based study. Rev Col Bras Cir. 2017;44(5):435-43. https://doi.org/10.1590/0100-69912017005003
25. Reinier KS, Vacek PM, Geller BM. Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women. Breast Cancer Res Treat. 2007;103(3):343-8. https://doi.org/10.1007/s10549-006-9375-9
26. International Atomic Energy Agency. The radiological accident in Goiânia [Internet]. Vienna: IAEA; 1988 [cited 2022 Feb 11]. Available from: Available from: https://www-pub.iaea.org/MTCD/publications/PDF/Pub815_web.pdf
27. Rahal RMS, Rocha ME, Freitas-Junior R, Correa RS, Rodrigues D, Martins E, et al. Trends in the incidence of breast cancer following the radiological accident in Goiânia: a 25-year analysis. Asian Pac J Cancer Prev. 2019;20(12):3811-16. https://doi.org/10.31557/apjcp.2019.20.12.3811
28. Lage LB, Freitas-Junior R, Corrêa RDS, Santos EE, Ferreira NC, Silva NC, et al. Evaluation of ionizing radiation as a risk factor for the incidence of breast cancer: long-term analysis after the cesium-137 accident in Goiânia, Brazil. An ecological study. Sao Paulo Med J. 2020;138(4):297-304. https://doi.org/10.1590/1516-3180.2020.0041.r1.04052020
29. Brasil. Instituto Nacional de Câncer. Ministério da Saúde. Câncer no Brasil: dados dos registros de base populacional [Internet]. Rio de Janeiro: INCA; 2010 [cited 2022 Apr 25]. Available from: https://www.inca.gov.br/publicacoes/livros/cancer-no-brasil-dados-dos-registros-de-base-populacional
30. Gebrim LH, Shida JY, Hegg R, Topis T, Mattar A. Avaliação do tempo de início do tratamento, estadiamento histopatológico e positividade dos biomarcadores (RE, RP, HER-2) em 3.566 pacientes tratadas pelo SUS no período de 2012 a 2014, no Hospital Pérola Byington. Rev Bras Mastologia. 2014;24(3):65-9. http://doi.org/10.5327/Z201400030002RBM
31. Freitas-Junior R, Rodrigues DCN, Corrêa RS, Oliveira LFP, Couto LS, Urban LABD, et al. Opportunistic mammography screening by the Brazilian Unified Health System in 2019. Mastology. 2020;30:e20190030. http://doi.org/10.29289/25945394202020190030
32. Soares LR, Curado MP, Freitas-Junior R. Breast cancer staging in population-based registries: an alert to the quality of information. Mastology. 2021;31:e20200067. http://doi.org/10.29289/2594539420200067
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2025 Lemos Nayara Alves de Freitas, Ruffo Freitas Junior, Silva Carleane Maciel Bandeira, Moreira Marise Amaral Rebouças, Élbio Candido de Paula, Nilceana Maya Aires Freitas, Edesio Martins, José Carlos de Oliveira, Carolina Maciel Reis Gonzaga, Marcus Nascimento Borges, Julio Roberto Macedo Bernardes Junior, Ricardo Francalacci Savaris, Régis Resende Paulinelli, Luiz Fernando Pádua Oliveira, Soares Leonardo Ribeiro, Rosemar Macedo Sousa Rahal
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
